Oxford Biomedica to host webinar showcasing the TetraVecta™ system
September 07, 2023 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica to host webinar showcasing the TetraVectaTM system Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led...
Oxford Biomedica launches TetraVecta - the next generation lentiviral vector system
May 15, 2023 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica launches TetraVectaTM - the next generation lentiviral vector system Oxford, UK – 15 May 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and...
Oxford Biomedica Appoints Leone Patterson as Non-Executive Director
April 26, 2023 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica Appoints Leone Patterson as Non-Executive Director Oxford, UK – 26th April 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led...
Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023
February 20, 2023 07:00 ET
|
Oxford BioMedica plc
Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023 Dr Mathias brings a wealth of experience in innovation, contract development and manufacturing to Oxford BiomedicaStuart...
Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer
November 22, 2022 07:00 ET
|
Oxford BioMedica plc
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of...
Oxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 million
November 14, 2022 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 million Oxford, UK – 14 November 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a...
Amendment of Short-Term Loan Facility into new Term Loan Facility With Oaktree
October 07, 2022 07:00 ET
|
Oxford BioMedica plc
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of...
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
September 15, 2022 07:00 ET
|
Oxford BioMedica plc
OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022 SIGNIFICANT STRATEGIC AND OPERATIONAL PROGRESS TOWARDS BECOMING A GLOBAL VIRAL VECTOR LEADER Oxford, UK – 15 September 2022:...
Oxford Biomedica Signs Licence & Supply Agreement with New Partner for LentiVector® Platform for CAR-T Therapy
July 26, 2022 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica Signs Licence & Supply Agreement with New Partner for LentiVector® Platform for CAR-T Therapy Oxford, UK – 26 July 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or...
Oxford Biomedica initiates new project with Orchard Therapeutics utilising LentiStable™ technology
July 26, 2022 07:00 ET
|
Oxford BioMedica plc
Oxford Biomedica initiates new project with Orchard Therapeutics utilising LentiStable™ technology Oxford, UK – 26 July 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a...